In tumor immunology, CD8+ cytotoxic T cells recognize the tumor antigen bound to the major histocompatibility complex class‐I (MHC‐I) molecules on the surface of tumor cells, thereby selectively killing these tumor cells. The gene discussed is CD8A; the disease is neoplasm.